Voyageur Pharmaceuticals (VM) News Today C$0.19 0.00 (0.00%) As of 05/2/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study ResultsApril 24, 2025 | finance.yahoo.comVoyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market LaunchApril 1, 2025 | finance.yahoo.comVoyageur Pharmaceuticals Ltd.: Voyageur Clarifies Terms of Previously Announced AgreementMarch 3, 2025 | finanznachrichten.deVoyageur Advances MRI Drug Development Using Next Generation Endohedral FullerenesFebruary 18, 2025 | finance.yahoo.comVoyageur Pharmaceuticals With CEO, Brent Willis | February 6th, 2025February 6, 2025 | msn.comVoyageur Receives $600K Grant From Alberta Innovates for Product DevelopmentFebruary 6, 2025 | finance.yahoo.comVoyageur Secures $687k of Additional Capital From Warrant ExercisesJanuary 24, 2025 | finance.yahoo.comVoyageur Pharmaceuticals is going global: Why it's time to buy the stockJanuary 23, 2025 | msn.comCanadian Investment Regulatory Organization Trading Halt - VMDecember 22, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - VMDecember 22, 2024 | finance.yahoo.comOne of the best Venture pharma stocks has grown even strongerOctober 3, 2024 | msn.comVoyageur Pharmaceuticals Ltd (VM)August 10, 2024 | investing.comUpdate - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium ContrastMay 28, 2024 | finance.yahoo.comVoyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonMarch 13, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd VMJanuary 3, 2024 | morningstar.comVoyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to DirectorsDecember 21, 2023 | stockhouse.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)December 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)October 24, 2023 | theglobeandmail.comVoyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast MediaSeptember 14, 2023 | stockhouse.comVoyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast mediaSeptember 14, 2023 | proactiveinvestors.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)September 7, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)June 20, 2023 | theglobeandmail.comVoyageur Pharmaceuticals completes field work at Frances Creek project in British ColumbiaMay 31, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast DrugsMay 24, 2023 | finance.yahoo.comVoyageur Pharmaceuticals unveils pioneering agreement with Rain Cage CarbonMay 24, 2023 | proactiveinvestors.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)May 10, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)May 4, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)May 2, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)April 29, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)April 28, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)April 26, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)April 22, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)April 21, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)April 14, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)April 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)April 6, 2023 | theglobeandmail.comVoyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imagingApril 4, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals preparing to launch sales of its first product in CanadaFebruary 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. (VM.V)February 10, 2023 | finance.yahoo.comVoyageur Pharmaceuticals completes second and final closing of its private placement for gross proceeds of $1,019,953.53January 23, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals launches SmoothX barium contrast media in CanadaDecember 8, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals issues deferred share units to directors under equity incentive compensation planDecember 5, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. Announces Equity Incentive CompensationDecember 3, 2022 | yahoo.comVoyageur Pharmaceuticals completes design for Alberta's first carbon-neutral pharmaceutical facilityNovember 1, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for CustomersOctober 31, 2022 | finance.yahoo.comVoyageur Pharmaceuticals LtdAugust 21, 2022 | reuters.comVoyageur Pharmaceuticals Ltd. Announces Increase to Proposed Private PlacementMay 31, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and DebtMay 10, 2022 | stockhouse.comVoyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment ReportFebruary 24, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd VYYRFJanuary 30, 2022 | stockhouse.com Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VM and its competitors with MarketBeat's FREE daily newsletter. Email Address VM Media Mentions By Week VM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VM News Sentiment▼0.000.58▲Average Medical News Sentiment VM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VM Articles This Week▼00▲VM Articles Average Week Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HLS Therapeutics News Today SugarBud Craft Growers News Today Medexus Pharmaceuticals News Today MediPharm Labs News Today Decibel Cannabis News Today Charlotte's Web News Today Crescita Therapeutics News Today Valeo Pharma News Today Delta 9 Cannabis News Today Entourage Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:VM) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyageur Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VM Stock Free VM Stock Alerts